As shown in Fig. 7, pargyline (an LSD1 inhibitor) was intraperitoneally injected from day 3 to day 14 after inoculation of MRMT-1 cancer cells to establish bone cancer pain model of rats. The gene discussed is KDM1A; the disease is bone cancer.